The Ohio State University Investigational Drug Services

Columbus, Ohio 43210

We've found

3 trials

at this facility

Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Columbus, OH

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Columbus, OH

Trial To Evaluate PF-06730512 In Adults With Primary Focal Segmental Glomerulosclerosis

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Columbus, OH

Use our guide to learn which trials are right for you!